XWELL, Inc. quarterly report, Q3 FY2013

Full document

Filing identity and reporting period

Important metadata discrepancy: The supplied filing is Vringo, Inc.’s Form 10-Q for the quarter ended September 30, 2013, signed November 7, 2013. It is not an XWELL, Inc. filing. The summary below describes the Vringo filing provided.

Vringo described itself as a development-stage company focused on developing, acquiring, licensing, and enforcing intellectual property, alongside mobile applications. Its portfolio included more than 500 patents and patent applications. The 2012 merger with Innovate/Protect was accounted for as a reverse acquisition.

Financial performance and position

  • Revenue: Third-quarter revenue was $50,000, down from $266,000 in Q3 2012. Nine-month revenue was $1.276 million, up from $266,000, primarily reflecting a $1 million Microsoft settlement and license payment received in May 2013. The Microsoft agreement also provides for 5% of certain future amounts Google pays, subject to a liability cap.
  • Costs, operating loss, and margins: Q3 cost of revenue was $6.725 million and total operating expenses were $11.226 million, resulting in an operating loss of $11.176 million. Nine-month cost of revenue was $19.557 million and operating loss was $32.197 million. Revenue was far below cost of revenue; a conventional positive gross margin was not reported.
  • Net loss: Q3 net loss was $10.560 million, versus $3.124 million in Q3 2012. Nine-month net loss was $33.464 million, versus $6.836 million in the prior-year period. Nine-month basic and diluted loss per share was $0.40.
  • Cash flow: Nine-month operating cash use was $17.384 million, versus $5.962 million in 2012. Investing cash use was $0.692 million, compared with $19.419 million, largely because the prior-year period included the Nokia patent acquisition. Financing provided $1.539 million, mainly from option and warrant exercises.
  • Liquidity and debt: At September 30, cash and cash equivalents were $40.436 million, short-term investments were $0.673 million, and net working capital was $37.596 million. Cash and cash equivalents had declined $16.524 million since year-end 2012. At November 5, cash, cash equivalents, and short-term investments totaled approximately $38.025 million. The filing reports no conventional debt balance; total liabilities included $4.126 million of warrant derivative liabilities. Management expected available funds to cover at least the next 12 months under current operating plans.
  • Balance sheet: Total assets were $138.483 million, including $65.965 million of goodwill and $30.360 million of net intangible assets. Stockholders’ equity was $130.090 million. Shares outstanding were 84,120,724 at quarter-end and 84,125,738 as of November 5.

Changes versus the prior comparable period

  • Nine-month revenue increased by $1.010 million, chiefly due to the Microsoft settlement; quarterly revenue declined by $216,000.
  • Nine-month operating loss widened by $17.982 million. Cost of revenue rose $13.581 million, mainly from patent litigation and consulting expenses, higher patent and acquired-technology amortization, and stock-based compensation. General and administrative expense rose $4.298 million; research and development expense rose $1.113 million.
  • Nine-month operating cash use increased by $11.422 million, which management attributed principally to higher litigation spending and post-merger staffing costs.
  • Non-operating results were volatile: the company recorded $1.220 million of net non-operating expense for the first nine months of 2013, compared with $7.303 million of income in 2012. Warrant fair-value changes and a $1.617 million expense associated with removing down-round protection affected results.

Outlook, commentary, and material risks

  • Outlook: No quantified revenue or earnings guidance was provided. Management expected operating cash use and patent enforcement costs to increase, while stating that current resources should fund operations for at least 12 months. It also said it might seek additional financing for acquisitions; such financing could dilute shareholders.
  • Litigation and contingencies: Vringo was pursuing patent cases involving Google and other defendants, and infringement actions against ZTE in several countries, as well as ASUS and ADT/Tyco. Appeals and requests for supplemental damages, interest, and post-judgment royalties remained pending in the Google case. The company disclosed possible adverse legal-fee exposure and guarantees in UK proceedings; it could not estimate potential future liabilities. The Nokia patent agreement also includes a 35% royalty on qualifying revenue above $22 million and other provisions that may trigger payments or repurchase rights.
  • Patent validity and business-model risk: Patent enforcement and licensing were central to the strategy, but outcomes, collections, timing, and the ability to monetize acquired patents were uncertain. Patent validity challenges remained ongoing in multiple jurisdictions. The filing noted that USPTO notices issued after quarter-end indicated challenged claims in two Lycos patents would remain valid and unchanged, while further proceedings remained relevant.
  • Other risks and unusual items: Level 3 warrant valuations rely on significant unobservable assumptions, making non-operating results sensitive to share price and other inputs. Stock-based compensation was $8.975 million for the nine months. The company also cited currency exposure, potential share dilution from warrants and options, and possible changes in patent laws or regulation.

Most important facts for investors to verify

  1. Confirm the issuer: the supplied filing is Vringo, Inc., not XWELL, Inc.; verify the intended company and reporting period.
  2. Check subsequent court, appeal, and patent-office outcomes, and distinguish jury awards or claims from amounts actually collected.
  3. Assess ongoing litigation spending and cash burn against the company’s stated 12-month liquidity outlook.
  4. Review the terms and potential dilution from outstanding warrants, options, and restricted stock units, as well as the warrant liability’s valuation assumptions.
  5. Verify the Microsoft payment, contingent 5% payment terms, liability cap, and any subsequent licensing or settlement receipts.
  6. Review potential legal-fee guarantees, Nokia contingent payments and restrictions, and any changes in contingencies after the filing date.